STESTERIS plc
AI adoption · Q1 2026 earnings call
Health CarePiloting
1
extracted from this call
2 / 5
directional only
Not disclosed
no breakout in this call
AI was mentioned only once on this call, briefly and in passing, as part of a description of a multiyear technology investment project to support service workflows in Healthcare and Life Sciences. No AI products, partnerships, or financial metrics were disclosed. The mention was aspirational and directional, with no quantification of AI-specific spend, outcomes, or revenue impact.
Adopter
See full leaderboard →27/ 100
49
stage: piloting · max spec: 2
0
no quantified disclosure
35
1 scope
internal_use
1 AI mention from this call.
Extracted verbatim from the STE Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T2Prepared remarks· CEO· Internal use
“kicking off a multiyear project to support our service workflows with upgraded technologies utilizing AI to improve quality, increase productivity and enhance the customer experience within both the Healthcare and Life Science segments”
— Daniel Carestio, STE earnings call
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- No quantification of AI-specific investment within the broader multiyear technology project budget.
- No detail on which AI technologies, vendors, or platforms are being utilized.
- No disclosure of expected productivity gains, cost savings, or revenue impact from the AI-enabled service workflow project.
- No analyst questions were asked about AI, and management did not elaborate beyond the single prepared-remarks mention.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.